Stock data
SELLAS Life Sciences Group, Inc. (SLS)
SELLAS Life Sciences Group, Inc. (SLS) reported net income of -US$26.86M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | — | — | -US$28.27M | -US$26.86M | — |
| 2024 | — | — | -US$31.51M | -US$30.88M | — |
| 2023 | US$0.00M | — | -US$37.87M | -US$37.34M | — |
| 2022 | US$1.00M | — | -US$41.95M | -US$41.30M | — |
| 2021 | US$7.60M | — | -US$25.29M | -US$20.70M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | — | -US$9.61M | — |
| 2026-03-31 | — | -US$8.41M | — |
| 2025-12-31 | — | -US$7.66M | — |
| 2025-09-30 | — | -US$6.79M | — |
| 2025-06-30 | — | -US$6.60M | — |
| 2025-03-31 | — | -US$5.81M | — |
| 2024-12-31 | — | -US$6.74M | — |
| 2024-09-30 | — | -US$7.11M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.